EPIVIR (Rebel Distributors Corp)
Welcome to the PulseAid listing for the EPIVIR drug offered from Rebel Distributors Corp. This Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Rebel Distributors Corp |
| NON-PROPRIETARY NAME: | lamivudine |
| SUBSTANCE NAME: | LAMIVUDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [Chemical/Ingredient],Nucleoside Reverse Transcriptase Inhibitors [MoA] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 1995-11-21 |
| END MARKETING DATE: | 0000-00-00 |
EPIVIR HUMAN PRESCRIPTION DRUG Details:
| Item Description | EPIVIR from Rebel Distributors Corp |
| LABELER NAME: | Rebel Distributors Corp |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 150(mg/1) |
| START MARKETING DATE: | 1995-11-21 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 21695-367_166abd26-675e-4832-9d18-0567f2a9d4e4 |
| PRODUCT NDC: | 21695-367 |
| APPLICATION NUMBER: | NDA020564 |
Other LAMIVUDINE Pharmaceutical Manufacturers / Labelers:
